Addressing spasticity-related pain in children with spastic cerebral palsy.
Children with spastic cerebral palsy (CP) often suffer pain as a result of their spasms. Some studies have suggested that the pain experienced by these children may be poorly controlled or respond poorly to treatment. Limited research is available that addresses the treatment of pain due to spasms in children. Therefore, clinicians do not have empirical evidence to guide their decisions. Many current treatment options have not been tested for their effect on pain. Previous research has been guided more by the ability of these treatments to increase functional abilities. Pain also is an important indicator of quality of life; however, this has been overlooked in research.
Roscigno
Cecelia I
CI
Children's Hospital and Regional Medical Center, Acute Care Float Pool, 4800 Sand Point Way NE, PO Box 5371, Seattle, WA 98105, USA.
D000700:Analgesics / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002547:Cerebral Palsy / Q000150:complications / Q000188:drug therapy* / Q000451:nursing*; D002648:Child; D004509:Education, Nursing, Continuing; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009465:Neuromuscular Agents / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing*
D000700:Analgesics; D009125:Muscle Relaxants, Central; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A